Proteostasis

PTI NASDAQ
1.081
+0.041
+3.94%
交易中 15:10 06/18 EDT
开盘
1.070
昨收
1.040
最高
1.090
最低
1.020
成交量
51.31万
成交均量(3M)
220.21万
52周最高
10.38
52周最低
0.9101
换手率
1.00%
市值
5,523.84万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Proteostasis PTI股票价格,Proteostasis股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. It has developed the Disease Relevant Translation (DRT) technology platform, a drug screening approach for identifying highly translatable therapeutics based on predictive and functionally pertinent phenotypic assays and disease relevant models. Using this platform, it has identified a new class of small molecules, amplifiers that modulate proteins in the proteostasis network. It is developing and intend to commercialize its lead amplifier of CFTR protein, PTI-428, to improve CFTR protein function. It also focuses on developing PTI-NC-733, PTI-130, Usp14 program and unfolded protein response (UPR) program. PTI-130 is a small molecule amplifier.
展开 >

最近浏览

名称
价格
涨跌幅